It’s hard to tell but these things have been rolled out quick with a broad approach of; don’t give any hospital any reason not to admit a sick patient during the pandemic. Normally a patient in outlier territory would have a hard time finding a long term acute care location if they were likely to lose the LTAC money. So they quickly instituted various add on and kicker “bonuses” such that nearly no patient would loss the LTAC money.
LTAC companies, in capitalism, would simply not accept patients if they thought they were too sick to make money on. Accepting parients put them out of business. The government wants hospitals to admit as many patients as they can in a health crisis. So , I feel this was more of a case where they acted quick and broad and didn’t actual think much about whether the drug was valid. If doctors want to prescribe it, it shouldn’t bankrupt the hospital where they work. The clinical value is up to the medical professions to figure out.